Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Roche's Tarceva (erlotinib)

Roche cancer drug Tarceva set for first-line licence

July 25, 2011 Sales and Marketing Cancer, Roche, Tarceva

Roche’s cancer drug Tarceva is on course to win a first-line indication in Europe for the first time after regulatory …
News

Afinitor poised to realise blockbuster ambitions?

July 25, 2011 Sales and Marketing Afinitor, Cancer, Novartis

Novartis’ Afinitor may be set to make good on its blockbuster promise after receiving European backing for its second licence …
News

Sanofi bags GSK’s Anne Whitaker for US role

July 25, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Sanofi has appointed Anne Whitaker president of its US pharmaceutical operations. She joins the company from GlaxoSmithKline, where she served …
Appointment

Lilly posts strong quarterly results, faces challenges ahead

July 22, 2011 Sales and Marketing lilly, patent expiry

Lilly edged toward double-digit growth in the second quarter, but looming patent expires threaten this trend. Second quarter revenue grew …
News

Merck and Roche extend Victrelis co-promotion deal to Europe

July 22, 2011 Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C

Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …
News

European reprieve for Takeda’s Actos

July 22, 2011 Sales and Marketing Actos, diabetes

Takeda’s Actos is likely to remain on the market in Europe but regulators want the diabetes drug to carry stronger …
News
Blog footer

Digital Pharma: Mobile app regulation

July 21, 2011 Medical Communications, Sales and Marketing Digital Phama blog, app, ipad, iphone, mobile

The FDA has proposed new rules for smartphone apps, but says the guidelines will only apply to a small number …
News
AZ's Brilinta (ticagrelor)

FDA approves AstraZeneca’s Brilinta after delay

July 21, 2011 Sales and Marketing AstraZeneca, Brilinta, Brilique, antiplatelet

The FDA has finally approved AstraZeneca’s oral blood thinner Brilinta after asking for more information on the drug last year.  …
News

MSI appoints new managing director

July 21, 2011 Sales and Marketing appointment, sales and marketing

UK-based pharmaceutical consultancy the MSI Consultancy has appointed Jon Bircher as managing director. He joined MSI in January 2006 from …
Appointment

AZ adds new heart warning to Seroquel

July 21, 2011 Sales and Marketing Seroquel, antipsychotic

AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …
News

Merck signs major deal with China’s Simcere

July 21, 2011 Sales and Marketing Merck, Simcere, emerging markets

Merck is to establish a joint venture with China’s Simcere focused on serving China’s rapidly expanding health care needs by …
News

NICE says no to breast cancer treatment Halaven

July 20, 2011 Sales and Marketing Eisai, Halaven, NICE

Eisai’s Halaven has been rejected by NICE in draft guidance for locally advanced or metastatic breast cancer. Halaven (eribulin) is …
News

Future of AZ-BMS diabetes drug in doubt

July 20, 2011 Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news

A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …
News
MSD's Victrelis (boceprevir)

Hep C drug Victrelis gains EU approval

July 20, 2011 Sales and Marketing Incivek, Victrelis, hepatitis C

Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …
News

Government seeks to salvage pharma pricing reforms

July 19, 2011 Sales and Marketing NICE, value-based pricing

The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026